WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · SB 1285

Legislative bill overview

SB 1285 establishes a pilot program for Overdose Prevention Centers (OPCs) in Connecticut, which are supervised facilities where people can consume pre-obtained drugs under medical supervision with access to naloxone and emergency services. The bill authorizes the state to operate these centers in select locations as a three-year pilot program to evaluate their effectiveness in reducing overdose deaths and connecting users to treatment services.

Why is this important

Overdose deaths remain a critical public health crisis in Connecticut and nationwide. OPCs are evidence-based interventions that have operated successfully in cities like New York, San Francisco, and internationally in Canada and Europe, demonstrating reductions in overdose fatalities, disease transmission, and emergency room costs while increasing treatment referrals. This pilot would test whether Connecticut can replicate these outcomes and potentially expand a harm-reduction approach to its opioid crisis.

Potential points of contention

  • Federal legal conflict: Operating OPCs may violate federal drug laws, creating liability concerns for the state and potentially triggering federal intervention or funding penalties
  • Community opposition: Neighborhoods where centers are located often resist their establishment due to concerns about public drug use, property values, and neighborhood safety perceptions
  • Cost and resource allocation: Questions about whether pilot funding represents efficient use of public health resources compared to other addiction interventions like treatment expansion or prevention programs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.